Showing results (71-80 of 93) with videos related to
Sort By:
Pageof 10
Talanta|January 26, 2015
ZnS:Mn nanoparticles functionalized by PAMAM-OH dendrimer based fluorescence ratiometric probe for cadmiumBruno B Campos, Manuel Algarra, Ksenija Radotić, et al.BMJ Open Quality|June 20, 2024
Improving quality of care by standardising patient data collection in electronic medical records in an oncology department in SpainGuillermo Alonso-Jáudenes Curbera, Martín Igor Gómez-Randulfe Rodríguez, Beatriz Alonso de Castro, et al.Journal of Ophthalmology|November 4, 2020
Evaluation of Anxiety Levels in Patients Undergoing Intravitreal Injections and Associated Risk Factors Related to the DiseaseJuan-Carlos Herranz-Heras, Almudena de-Pablo-Cabrera, Beatriz Alonso-Martín, et al.Environmental and Molecular Mutagenesis|May 19, 2016
No cytotoxicity or genotoxicity of graphene and graphene oxide in murine lung epithelial FE1 cells in vitroStefan Bengtson, Kirsten Kling, Anne Mette Madsen, et al.Plos One|June 2, 2017
Differences in inflammation and acute phase response but similar genotoxicity in mice following pulmonary exposure to graphene oxide and reduced graphene oxideStefan Bengtson, Kristina B Knudsen, Zdenka O Kyjovska, et al.Scientific Reports|August 26, 2022
Efficacy, safety and prognostic factors in patients with refractory metastatic colorectal cancer treated with trifluridine/tipiracil plus bevacizumab in a real-world settingNieves Martínez-Lago, Teresa Calleja Chucla, Beatriz Alonso De Castro, et al.Human Mutation|March 1, 2019
RECQL5: Another DNA helicase potentially involved in hereditary breast cancer susceptibilityAlejandra Tavera-Tapia, Miguel de la Hoya, Oriol Calvete, et al.British Journal of Cancer|August 1, 2019
A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patientsElena Elez, Carles Pericay, Manuel Valladares-Ayerbes, et al.BMJ Open|May 19, 2023
Point-of-care ultrasound for tuberculosis diagnosis in children: a Médecins Sans Frontières cross-sectional study in Guinea-BissauLaura Moretó-Planas, María José Sagrado, Raman Mahajan, et al.Plos One|June 3, 2022
Efficacy and safety of FOLFIRI/aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after failure of an oxaliplatin-based regimenNieves Martínez-Lago, Soledad Cameselle García, Beatriz Alonso de Castro, et al.Pageof 10